Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Food safety scares and recalls have pressured restaurant and grocery stocks in 2026, raising concerns about costs, supply chains, and brand trust.
Advanced Micro Devices shares declined before the bell on Wednesday as the chipmaker's stronger-than-expected revenue forecast fell short of lofty expectations and investors sought clearer signs that a multibillion-dollar AI spending boom will translate into faster growth. The move underscores elevated expectations facing AMD as it aims to challenge Nvidia's dominance amid intensifying competition with Intel racing to regain technology leadership after strong results. "We suspect expectations had moved higher following Intel's results a couple of weeks ago, and the buyside already has a fairly bullish outlook," said Stacy Rasgon, analyst at Bernstein.
Advanced Micro Devices shares declined before the bell on Wednesday as the chipmaker's stronger-than-expected revenue forecast fell short of lofty expectations and investors sought clearer signs that a multibillion-dollar AI spending boom will translate into faster growth. The move underscores elevated expectations facing AMD as it aims to challenge Nvidia's dominance amid intensifying competition with Intel racing to regain technology leadership after strong results. "We suspect expectations had moved higher following Intel’s results a couple of weeks ago, and the buyside already has a fairly bullish outlook," said Stacy Rasgon, analyst at Bernstein.
A rally across global stock markets continued, with sentiment boosted by the prospect of a U.S.-Iran agreement to reopen the Strait of Hormuz.
Investing.com -- Novo Nordisk (CSE:NOVOb) (NYSE:NVO) hiked its full-year guidance, saying annual sales and operating profit should decline less than previously expected as demand for its weight-loss drugs continues unabated.
Elon Musk said on Tuesday SpaceX will build its AI infrastructure exclusively on Nvidia chips going forward.
Zeta (ZETA) delivered earnings and revenue surprises of -10.00% and +5.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The deal will give Hearst full ownership of prominent brands such as Lifetime and The History Channel.
On the latest episode of the AI Investor Podcast, 24/7 Wall St. Analyst Austin Smith opens with a puzzle: two companies are being treated in opposite ways for the same underlying behavior. Microsoft is up roughly 16% after Azure growth accelerated from 38% to 43%, with guidance pointing to 45–46%, vindicating a capex program the market had criticized. Meta, meanwhile, is down about 10% at roughly 20x earnings despite 28% top-line growth — and is being punished for the same infrastructure spending, even after Zuckerberg argued that Meta rents out compute at a markup over its cost. Co-host Eric Bleeker's answer is that both moves are likely overreactions, and that the real variable is what each company said versus what Wall Street wanted to hear. Microsoft delivered on message: Azure at a $124 billion run rate, 90% of cloud demand coming from outside the frontier labs, and no capex increase. He frames Microsoft's position as a prisoner's dilemma, since compute routed to Azure is compute unavailable for its own AI products, and argues Microsoft CEO Satya Nadella relented under pressure from prior quarters. He compares the market's discomfort with capex growth to Apple's mid-decade smartphone choppiness versus Google's steadier trajectory. Meta hit every wrong note: an EPS miss on one-time costs, decelerating guidance, Zuckerberg walking back the cloud-capacity revenue opportunity, and incremental compute directed toward Meta Superintelligence rather than the core ad business. Eric estimates the justified moves were only a few percent in either direction, with the rest attributable to PR and positioning. He credits Microsoft's software exposure as valuable diversification, but concludes the share-price gap doesn't reflect any real difference in business trajectory.
Sales to data centers grew to 58% of revenue for the company, which has pivoted hard to serving the fastest-growing types of AI workloads.
AMD earnings beat on revenue, profit, and margin, and guidance hit $13 billion. The stock still fell 8% after hours.
Oil prices continued their slide and stocks rallied after Scott Bessent said a deal with Iran to reopen the Strait of Hormuz could come “today or tomorrow.” The Dow industrials climbed 1.7% and closed above 54,000 for the first time.
Chipotle Mexican Grill’s stock is taking a hit after the chain pulled ingredients tied to a Salmonella outbreak.
By Abhirup Roy SAN FRANCISCO, Aug 4 (Reuters) - U.S.
Novo now expects underlying sales and operating profit in the range of 0% to –6% for the year.
Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.
Chipotle Mexican Grill has pulled jalapeños from several Minnesota restaurants following a state Salmonella outbreak that has infected more than 100 people.
U.S.-traded shares of Novo Nordisk are down more than 6% due to a sales shortfall for its new Wegovy weight-loss pill and a disappointing study outcome for a next-generation weight-loss drug. Overall, the company sees the potential for a full-year sales decline of up to 6%, better than its previous view that sales could drop up to 12%. Novo also disclosed that its experimental drug CagriSema failed to show comparable blood-sugar reduction to Eli Lilly’s tirzepatide in a new study of people with Type 2 diabetes.
Investing.com -- Citizens downgraded eBay to Market Perform from Market Outperform, saying the risk-reward has become more balanced as intensifying competition in online resale and heavier investment in Depop are likely to weigh on profitability.
Investing.com -- Jefferies downgraded Cigna to Hold from Buy, arguing that a growing list of earnings headwinds and limited catalysts outweigh the stock's discounted valuation, while cutting its price target to $307 from $336.
Novo Nordisk stock plummeted Tuesday after the obesity kingpin unexpectedly released its second-quarter earnings a day early.
Roblox (RBLX) stock fell hard over the past year, but its user base kept growing, and plenty of investors were willing to wait for a turnaround. That patience ran out on July 31. Roblox reported second-quarter results, then told the market something concerning. The company expects its ...
Fuelled by blockbusters such as Eliquis, Pfizer is cementing its post-Covid revenue legacy.
POWL's fiscal Q3 earnings and revenues miss estimates, even as record orders and a $2.4 billion backlog strengthen its outlook.
The lawsuit was filed in California, which has a law that bans deceptive reference prices.
PHIN misses Q2 earnings estimates despite higher sales as employee costs and product mix weigh on margins.
Avis Budget's Q2 earnings miss exposed soft rental demand, while fleet cuts, record utilization and reaffirmed 2026 EBITDA guidance supported margins.
China Renaissance, DZ Bank and Phillip Securities downgraded AAPL stock, citing a combination of rising component costs, supply constraints and uncertainty around the pace of returns from Apple Intelligence.
Walmart (NYSE:WMT) shares moved lower in U. S.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
